Systemic Sclerosis

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Systemic Sclerosis
x

Are you interested in possibly participating in a clinical trial for Warm Autoimmune Hemolytic Anemia?

Read More

Following specialists treat  Systemic Sclerosis. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month


Submit

66%

66%

66%

66%

87%

66%

87%

0%20%40%60%80%

Specialty scores for Systemic Sclerosis

Overview

Source: In partnership with Genetic and Rare Diseases Information Center, funded by the National Center for Advancing Translational Sciences, and the National Human Genome Research Institute https://rarediseases.info.nih.gov/gard.

Terms of Use

Systemic scleroderma

overview Question

What is systemic scleroderma?

Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs. It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connective tissues. The signs and symptoms of systemic scleroderma usually begin with episodes of Raynaud's phenomenon, which can occur weeks to years before fibrosis. This may be followed by puffy or swollen hands before the skin becomes thickened and hard. Fibrosis can also affect internal organs and can lead to impairment or failure of the affected organs. The most commonly affected organs are the esophagus, heart, lungs, and kidneys.

There are three types of systemic scleroderma, defined by the tissues affected in the disorder.

Date Modified: 2013-01-30T19:52:00

basic Questions

What causes systemic scleroderma?

The exact, underlying cause of systemic sclerosis is unknown. The cause appears to involve some injury to the cells that line blood vessels, resulting in excessive activation of dermal connective tissue cells, called fibroblasts. Fibroblasts normally produce collagen and other proteins. Build-up of collagen in the skin and other organs causes the signs and symptoms of the condition.

It is suspected that scleroderma may develop from a variety of factors, which may include:

  • Abnormal immune or inflammatory activity
  • Genetic susceptibility: while no specific genes are thought to cause scleroderma, certain genes (or combination of genes) may increase a person's risk to be affected. However, the condition is not passed directly from parents to children.
  • Environmental triggers: suspected triggers may include infections; injury; drugs (e.g. vitamin K, cocaine, penicillamine, appetite suppressants and some chemotherapeutic agents); and chemicals (e.g. silica, organic solvents, pesticides, aliphatic hydrocarbons and epoxy resin).
  • Hormones: because women develop scleroderma more often than men, researchers suspect that hormones may play a role. However, the role of female hormones has not been proven.

Widespread scleroderma can also occur in association with other autoimmune diseases, including systemic lupus erythematosus and polymyositis.

Date Modified: 2014-04-09T10:12:00

Is systemic scleroderma inherited?

Most cases of systemic scleroderma are sporadic and are not inherited. This means the condition typically occurs in people with no history of the condition in their family. Some people with systemic scleroderma have relatives with other autoimmune disorders, and a few cases of the condition have been reported to run in families. However, the condition is not caused by a single gene that is passed on to offspring. Multiple genetic and environmental factors likely interact to put someone at an increased risk to develop the condition.

Date Modified: 2014-04-09T10:13:00

Is genetic testing available for systemic scleroderma?

Because systemic scleroderma is not caused by a mutation in any one specific gene, clinical genetic testing to confirm a diagnosis or identify a "carrier" is not currently available.  Even if someone is known to carry a version of a gene that may make them susceptible to the condition, it does not mean they will definitely develop the condition.

You can view a list of centers that may be involved in research projects on systemic scleroderma on Orphanet's Web site.

You can also view a list of clinical trials involving people with systemic scleroderma on ClinicalTrials.gov.

People interested in learning more about genes and genetic testing for systemic scleroderma should speak with a genetics professional.

Date Modified: 2014-04-09T10:13:00

Presentation(s)

Abnormality of the gastric mucosa

Acrocyanosis

Arthralgia

Arthritis

Atypical scarring of skin

Autoimmunity

Chest pain

Chondrocalcinosis

Edema

Hyperkeratosis

Lack of skin elasticity

Myalgia

Nausea and vomiting

Skeletal muscle atrophy

Weight loss

Abnormality of the myocardium

Abnormality of the pericardium

Feeding difficulties in infancy

Gangrene

Malabsorption

Mucosal telangiectasiae

Myositis

Pulmonary fibrosis

Pulmonary infiltrates

Respiratory insufficiency

Skin ulcer

Telangiectasia of the skin

Trismus

Xerostomia

Abnormal renal physiology

Abnormal tendon morphology

Arrhythmia

Bowel incontinence

Coronary artery disease

Erectile abnormalities

Hypertensive crisis

Irregular hyperpigmentation

Migraine

Narrow mouth

Osteolysis

Osteomyelitis

Peripheral neuropathy

Pulmonary hypertension

Seizures

Abnormality of chromosome stability

Abnormality of the abdomen

Autosomal dominant inheritance

Calcinosis

Sclerodactyly

Scleroderma

Telangiectasia